Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine XR in Multisomatoform Disorder
NCT00546923Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in somatic symptom disorder (SSD) comparing Venlafaxine XR with Placebo (2 arms). Primary endpoint: Patient Health Questionnaire-15 at 12 weeks. Started Aug 2004; status: completed.
02
Drugs
venlafaxine
03
Conditions
somatic symptom disorder (SSD)
Beyond the preview
Go deeper on NCT00546923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546923.